In the BioHarmony Drug Report Database

"Preview" Icon

Warfarin

Athrombin, Coumadin, Panwarfin (warfarin) is a small molecule pharmaceutical. Warfarin was first approved as Athrombin on 1982-01-01. It is used to treat atrial fibrillation, postoperative complications, pulmonary embolism, stroke, and thromboembolism amongst others in the USA. The pharmaceutical is active against vitamin K epoxide reductase complex subunit 1. In addition, it is known to target Uncharacterized protein.

 

Trade Name

 

Athrombin, Coumadin, Panwarfin
 

Common Name

 

warfarin
 

ChEMBL ID

 

CHEMBL1464
 

Indication

 

atrial fibrillation, postoperative complications, pulmonary embolism, stroke, thromboembolism, thrombophlebitis
 

Drug Class

 

Warfarin analogs

Image (chem structure or protein)

Warfarin structure rendering